EFFECTS OF THE CATHEPSIN K INHIBITOR, ONO-5334, ON BMD AS MEASURED BY 3D QCT IN THE HIP AND THE SPINE AFTER 2 YEARS OF TREATMENT

被引:0
|
作者
Engelke, Klaus [1 ]
Nagase, Shinishi [2 ]
Fuerst, Thomas [5 ]
Eastell, Richard [3 ]
Genant, Harry K. [4 ]
Samll, Maria [2 ]
Kuwajama, T. [2 ]
Deacon, Steve [2 ]
机构
[1] Synarc, Hamburg, Germany
[2] Ono Pharma UK, London, England
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Synarc, Newark, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S62 / S63
页数:2
相关论文
共 25 条
  • [1] EFFECTS OF THE CATHEPSIN K INHIBITOR, ONO-5334, ON BMD AS MEASURED BY 3D QCT IN THE HIP AND THE SPINE AFTER 12 MONTHS TREATMENT
    Engelke, Klaus
    Nagase, Shinichi
    Fuerst, Thomas
    Eastell, Richard
    Genant, Harry
    Small, Maria
    Kuwayama, Tomohiro
    Deacon, Steve
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 100 - 101
  • [2] Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Hashimoto, Yasuaki
    Ochi, Yasuo
    Tanaka, Makoto
    Kawabata, Kazuhito
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2019, 2019
  • [3] Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Kayasuga, Ryoji
    Kawada, Naoki
    Kunishige, Akiko
    Hashimoto, Yasuaki
    Tanaka, Makoto
    Sugitani, Masafumi
    Kawabata, Kazuhito
    BONE, 2011, 49 (06) : 1351 - 1356
  • [4] Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
    Makoto Tanaka
    Yoshitaka Hashimoto
    Chihiro Hasegawa
    Steve Deacon
    Richard Eastell
    BMC Musculoskeletal Disorders, 18
  • [5] Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
    Tanaka, Makoto
    Hashimoto, Yoshitaka
    Hasegawa, Chihiro
    Deacon, Steve
    Eastell, Richard
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [6] Antiresorptive activity of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis.
    Tanaka, Makoto
    Hashimoto, Yoshitaka
    Hasegawa, Chihiro
    Deacon, Steve
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S382 - S382
  • [7] Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized, cynomolgus monkeys
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Kayasuga, Ryoji
    Kawada, Naoki
    Kunishige, Akiko
    Hashimoto, Yasuaki
    Tanaka, Makoto
    Sugitani, Masafumi
    Kawabata, Kazuhito
    BONE, 2014, 65 : 1 - 8
  • [8] EFFECTS OF THE NOVEL CATHEPSIN K INHIBITOR, ONO-5334, ON BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN: A MULTIPLE DOSE PHASE I STUDY
    Nagase, S.
    Ohyama, M.
    Small, M.
    Kuwayama, T.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 338 - 338
  • [9] Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys
    Yamada, Hiroyuki
    Ochi, Yasuo
    Mori, Hiroshi
    Nishikawa, Satoshi
    Hashimoto, Yasuaki
    Nakanishi, Yasutomo
    Tanaka, Makoto
    Bruce, Mark
    Deacon, Steve
    Kawabata, Kazuhito
    BONE, 2016, 86 : 43 - 52
  • [10] Increased cortical bone mass by treatment with ONO-5334, a cathepsin K inhibitor, is associated with high bone strength compared to alendronate in ovariectomized monkeys
    Mori, H.
    Ochi, Y.
    Yamada, H.
    Nakanishi, Y.
    Nishikawa, S.
    Hashimoto, Y.
    Sugitani, M.
    Kawabata, K.
    BONE, 2012, 50 : S157 - S157